Recovery moves faster through each phase, and repaired tissue quality is better
According to Sarwer and Maccarone, scientists believe these shifts in mood are caused by how the drug changes the brains central reward pathways by diminishing responses to the neurotransmitter dopamine
Even with advanced pharmacological treatments, the integration of these therapies with effective lifestyle changes continues to be a complex and ongoing challenge
Manufactured in Valladolid, Spain by an ISO 13485:2016 + GMP certified facility
Our research and development efforts are focused on identifying and formulating lipid matrices that can enhance the bioavailability of GLP-1 stimulating compounds, improve gut microbiome composition, and ultimately contribute to more effective and accessible wellness solutions for a broader consumer base
Microbiota y GLP-1 La fermentacin de la fibra por la microbiota genera cidos grasos de cadena corta (SCFA) que pueden modular la secrecin de GLP-1 (6)